Haematologica, Vol 92, Issue 9, 1266-1267 doi:10.3324/haematol.11379
Copyright © 2007 by Ferrata Storti Foundation
Prasenjit Guchhait* ,
Swapan K Dasgupta* ,
Anhquyen Le ,
Sarvari Yellapragada ,
José A. López ,
Perumal Thiagarajan
Increased exposure of sickle red blood cells to phosphatidylserine promotes its adhesion to the endothelium. A monoclonal antibody to lactadherin, a phosphatidylserine binding protein, inhibits sickle cell adhesion to histamine-stimulated endothelial cells in flowing blood. Added lactadherin enhances the adhesion via the integrin
Vß3. These results indicate that lactadherin can mediate phosphatidyl-serine-expressing sickle cell adhesion to the endothelium.
Lactadherin-dependent adhesion of sickle red blood cells was inhibited by abciximab, an antibody fragment that targets the ßsubunit of integrin Vß3 (Figure 2A). Furthermore, phosphatidylserine vesicles also inhibited sickle cell adhesion. These results show that lactadherin bridges the phosphatidylserine-expressing sickle red blood cells and endothelial cells by binding to phosphatidylserine on red blood cell surface and integrin V'3 on the endothelial cell surface.
Lactadherin had no effect on the basal adhesion of normal red blood cells (Figure 2B). However, when normal red blood cells were pretreated with N-ethylmaleimide and calcium ionophore A23187, which induces transbilayer movement of phosphatidylserine from the inner to the outer leaflet of the plasma membrane bilayer,8 the addition of lactadherin significantly increased adhesion (Figure 2B). The abnormal adhesion of sickle cells to vascular endothelium involves multiple ligands and receptors and correlates strongly with severity of vasoocclusive crisis.1 Several studies have also shown that sickle cells express a significant quantity of phosphatidyl-serine on their outer surface.2,9
* These two authors contributed equally.
Copyright © 2007 by Ferrata Storti Foundation
Red Cell Disorders |
Lactadherin mediates sickle cell adhesion to vascular endothelial cells in flowing blood
Department of Medicine (Thrombosis Research) (PG, SY JAL, PT) and Pathology Baylor College of Medicine (SKD, AL, PT) and Michael E. DeBakey Veterans Affairs Medical Center Houston, Tx, USA (PT)
Correspondence: Perumal Thiagarajan, MD, Michael E. DeBakey VA Medical Center, Mail stop #113, 2002 Holcombe Blvd, Houston, TX 77030, USA. Phone: international +1.713.7947873. Fax: international +1.713.7947657. E-mail.perumalt{at}bcm.tmc.edu
ABSTRACT
 TOP ABSTRACT References |
|---|
Increased exposure of sickle red blood cells to phosphatidylserine promotes its adhesion to the endothelium. A monoclonal antibody to lactadherin, a phosphatidylserine binding protein, inhibits sickle cell adhesion to histamine-stimulated endothelial cells in flowing blood. Added lactadherin enhances the adhesion via the integrin
Vß3. These results indicate that lactadherin can mediate phosphatidyl-serine-expressing sickle cell adhesion to the endothelium.
Key words: lactadherin, sickle cell anemia, phosphatidyl-serine, endothelial adhesion.
In sickle cell anemia, there is a strong correlation between the red cell adhesion to endothelium and clinical severity.1 Increased exposure of sickle red blood cells to phosphatidylserine is one the factors that promote adhesion2. Lactadherin (also known as milk fat globule-EGF factor 8), is a phosphatidylserine-binding glycoprotein containing an EGF-like domain at the amino terminus with the RGD sequence and two C-domains at the carboxy terminus. It promotes engulfment of phosphatidylserine-containing apoptotic cells3 and sickle red blood cells4 by macrophages. We have examined its role in sickle cell adhesion to the endothelium.
Bovine Lactadherin was isolated as described before.4,5 The monoclonal antibody L688 (IgA
) was derived from a mouse immunized with bovine lactadherin.6 The splenocytes were harvested and fused to non-secreting myeloma cell line NS-1. The resulting hybrids were screened for antibody production against human recombinant lactadherin by ELISA. One hybrid that showed significant binding was expanded, retested, and cloned by limiting dilution. The antibody was purified from the tissue culture supernatant by ammonium sulfate precipitation and gel filtration on Sephacryl S 200 (Amersham-Pharmacia, Piscataway, NJ, USA).
After receiving their written informed consent, blood was collected from volunteers or patients with sickle cell anemia (homozygous SS). The study was approved by the committee for the protection of human subjects at the Baylor College of Medicine. None of the patients were clinically in a pain crisis. Washed red blood cells were incubated with N-ethylmaleimide (10 mM) and ionophore A23187 (4 µM) to induce transbilayer movement of phosphatidylserine as described by Kuypers et al.2 A parallel-plate flow chamber was assembled with the histamine-treated endothelial cells forming the bottom of the flow chamber and mounted onto an invertedstage microscope equipped with a high-speed digital camera as previously described.7 Washed red cells, resuspended at 1% hematocrit in autologous plasma or in serum-free medium 199, containing 1% bovine serum albumin, were perfused through the chamber to generate a wall shear stress of 1.0 dyne/cm2 for five minutes and the images of adherent red cells were acquired. These images were analyzed offline using MetaMorph software (Universal Images, West Chester, PA) in 15 random fields at 40 xmagnification. The adhesion is expressed as the number of red blood cells in a field.
All experimental values are represented as mean ± standard error. Analysis of the difference was performed using Student’s t-test for paired and unpaired data. Values were regarded significant at p<0.05.
Sickle red blood cells, in autologous platelet-free plasma, adhered to histamine-treated human umbilical vein endothelial cells avidly at the venular shear stress of 1.0 dyne/cm2 in a parallel-plate flow chamber as described.1 L688 significantly inhibited the adhesion compared to an isotype matched control monoclonal antibody MOPC-320 (Figure 1A). In five separate experiments involving five patients, L688 inhibited the adhesion by 24–30% (p<0.001). These results show that lactadherin is one of the molecules that mediate adhesion of sickle red blood cells to the endothelium under flow in a whole blood milieu. In a separate set of experiments, we examined the adhesion in a serum-free tissue culture medium. Lactadherin stimulated sickle red blood cell adhesion to endothelial cells in a concentration-dependent manner (Figure 1B).
 View larger version (11K): [in a new window] [Download PPT slide] |
Figure 1. A. Inhibition of sickle cell adhesion to endothelium by antilactadherin antibody. Washed sickle red blood cells, resuspended in autologous plasma (1% hematocrit), were perfused over histamine-stimulated HUVEC monolayers at a shear stress of 1.0 dyne/cm2 for 5 minutes in a parallel plate flow chamber. The adherent red blood cells were quantified and the adhesion is expressed as the number of red blood cells per high power field. Closed bar, buffer without any antibody; gray bar, control antibody MOPC-320 (20 µg/mL) and open bar, antilactadherin antibody L688 (20 µg/mL). The results are the means and standard errors of measurements in 15 random fields. *denotes a p<0.001 when compared to buffer. B. Washed sickle red blood cells, resuspended in serum-free medium 199, were perfused at a shear stress of 1 dyne/cm2 over histamine-stimulated endothelial cell monolayer for 5 minutes. Adhesion was measured at various concentrations of lactadherin as described in methods. The results are expressed as means and standard errors for each patient. *denotes a p<0.001 when compared to buffer.
|
Vß3 (Figure 2A). Furthermore, phosphatidylserine vesicles also inhibited sickle cell adhesion. These results show that lactadherin bridges the phosphatidylserine-expressing sickle red blood cells and endothelial cells by binding to phosphatidylserine on red blood cell surface and integrin V'3 on the endothelial cell surface.
 View larger version (9K): [in a new window] [Download PPT slide] |
Figure 2. Panel A. Inhibition of sickle red blood cell adhesion to endothelial cell monolayers. The lactadherin-dependent adhesion of washed sickle red blood cells to stimulated endothelial cell monolayers was measured at a shear stress of 1 dyne/cm2 in the presence of various agents (20 µg/mL). PC, phosphatidylcholine vesicles. PS, phosphatidyl-serine vesicles. *denotes a p value of <0.05 when compared to buffer. Panel B. Effect of lactadherin on the adhesion of phosphatidylserine-expressing normal red blood cells to endothelial cells. Washed normal red blood cells were treated with ionophore A23187 and N-ethylmaleimide and perfused at a shear stress of 1 dyne/cm2 over histamine-stimulated endothelial cell monolayer for 5 minutes. Red blood cell adhesion was measured in the presence or absence of lactadherin (10 µg/mL). * denotes a p value of <0.05 when compared to buffer.
|
The data presented here show that lactadherin, which is present in plasma,10 is a mediator of phosphatidyl-serine-expressing sickle cell adhesion to the endothelium under physiological venular shear stress via Vß3. Lactadherin also promotes the phagocytosis of phosphatidylserine-expressing sickle red blood cells by macrophages.4 We suggest that lactadherin-bound sickle red blood cells that escape ingestion by macrophages are more adhesive towards endothelium. In conclusion, lactadherin appears to be involved both in sickle cell clearance from the circulation and in adhesion to the endothelium.
Footnotes
* These two authors contributed equally.
Funding: supported by a grant from the Veterans Affairs Research Service.
References
|
TOPABSTRACTReferences |
|---|
- Hebbel RP. Adhesive interactions of sickle erythrocytes with endothelium. J Clin Invest 1997;100:S83-6.[Web of Science][Medline]
- Kuypers FA, Lewis RA, Hua M, Schott MA, Discher D, Ernst JD, et al. Detection of altered membrane phospholipid asymmetry in subpopulations of human red blood cells using fluorescently labeled annexin V. Blood 1996;87:1179-87.
[Abstract/Free Full Text] - Hanayama R, Tanaka M, Miwa K, Shinohara A, Iwamatsu A, Nagata S. Identification of a factor that links apoptotic cells to phagocytes. Nature 2002;417:182-7.[CrossRef][Medline]
- Dasgupta SK, Thiagarajan P. The role of lactadherin in the phagocytosis of phosphatidylserine-expressing sickle red blood cells by macrophages. Haematologica 2005;90:1267-8.
[Abstract/Free Full Text] - Dasgupta SK, Guchhait P, Thiagarajan P. Lactadherin binding and phosphatidylserine expression on cell surface-comparison with annexin A5. Transl Res 2006;148:19-25.[CrossRef][Web of Science][Medline]
- Fox PC, Berenstein EH, Siraganian RP. Enhancing the frequency of antigen-specific hybridomas. Eur J Immunol 1981;11:431-4.[CrossRef][Web of Science][Medline]
- Natarajan M, Udden MM, McIntire LV. Adhesion of sickle red blood cells and damage to interleukin-1 beta stimulated endothelial cells under flow in vitro. Blood 1996;87:4845-52.
[Abstract/Free Full Text] - de Jong K, Larkin SK, Styles LA, Bookchin RM, Kuypers FA. Characterization of the phosphatidylserine-exposing subpopulation of sickle cells. Blood 2001;98:860-7.
[Abstract/Free Full Text] - Yasin Z, Witting S, Palascak MB, Joiner CH, Rucknagel DL, Franco RS. Phosphatidylserine externalization in sickle red blood cells: associations with cell age, density, and hemoglobin F. Blood 2003;102:365-70.
[Abstract/Free Full Text] - Ceriani RL, Sasaki M, Sussman H, Wara WM, Blank EW. Circulating human mammary epithelial antigens in breast cancer. Proc Natl Acad Sci USA 1982;79:5420-4.
[Abstract/Free Full Text]
This article has been cited by other articles:
 |
|
 |
|
  S. K. Dasgupta, H. Abdel-Monem, P. Niravath, A. Le, R. V. Bellera, K. Langlois, S. Nagata, R. E. Rumbaut, and P. Thiagarajan Lactadherin and clearance of platelet-derived microvesicles Blood, February 5, 2009; 113(6): 1332 - 1339. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||